Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

628 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Graft failure after donor leucocyte infusion in relapsed chronic myeloid leukaemia: successful treatment with cyclophosphamide and antithymocyte globulin followed by peripheral blood stem cell infusion.
Keil F, Kalhs P, Haas OA, Fritsch G, Mitterbauer G, Brugger S, Lechner K, Schwarzinger I, Mannhalter C, Linkesch W, Kurz M, Greinix HT. Keil F, et al. Among authors: lechner k. Br J Haematol. 1996 Jul;94(1):120-2. doi: 10.1046/j.1365-2141.1996.d01-1770.x. Br J Haematol. 1996. PMID: 8757519
Relapse of Philadelphia chromosome positive acute lymphoblastic leukaemia after marrow transplantation: sustained molecular remission after early and dose-escalating infusion of donor leucocytes.
Keil F, Kalhs P, Haas OA, Fritsch G, Reiter E, Mannhalter C, Lechner K, Leitner G, Greinix HT. Keil F, et al. Among authors: lechner k. Br J Haematol. 1997 Apr;97(1):161-4. doi: 10.1046/j.1365-2141.1997.262674.x. Br J Haematol. 1997. PMID: 9136959 Free article.
Competitive CBFbeta/MYH11 reverse-transcriptase polymerase chain reaction for quantitative assessment of minimal residual disease during postremission therapy in acute myeloid leukemia with inversion(16): a pilot study.
Laczika K, Novak M, Hilgarth B, Mitterbauer M, Mitterbauer G, Scheidel-Petrovic A, Scholten C, Thalhammer-Scherrer R, Brugger S, Keil F, Schwarzinger I, Haas OA, Lechner K, Jaeger U. Laczika K, et al. Among authors: lechner k. J Clin Oncol. 1998 Apr;16(4):1519-25. doi: 10.1200/JCO.1998.16.4.1519. J Clin Oncol. 1998. PMID: 9552061
Recombinant human megakaryocyte growth and development factor increases levels of circulating haemopoietic progenitor cells post chemotherapy in patients with acute myeloid leukaemia.
Geissler K, Kabrna E, Stengg S, Schwarzinger I, Knöbl P, Valent P, Eichinger S, Barge A, Lechner K. Geissler K, et al. Among authors: lechner k. Br J Haematol. 1998 Jul;102(2):535-43. doi: 10.1046/j.1365-2141.1998.00789.x. Br J Haematol. 1998. PMID: 9695971 Free article. Clinical Trial.
Quantification of minimal residual disease in patients with BCR-ABL-positive acute lymphoblastic leukaemia using quantitative competitive polymerase chain reaction.
Mitterbauer G, Nemeth P, Wacha S, Cross NC, Schwarzinger I, Jaeger U, Geissler K, Greinix HT, Kalhs P, Lechner K, Mannhalter C. Mitterbauer G, et al. Among authors: lechner k. Br J Haematol. 1999 Sep;106(3):634-43. doi: 10.1046/j.1365-2141.1999.01605.x. Br J Haematol. 1999. PMID: 10468851 Free article.
628 results